GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Intermune, Inc. (ITMN) [hlAlert]

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital
disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.
( Total: 24 Current Stock Recommendations )
Intermune, Inc.   (24)
Hold 33% Buy 67%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Hold ITMN
up 66.80 %

Rating:
Hold ITMN
up 307.43 %
Intermune, Inc. (ITMN) downgraded to Hold by Stifel
Monday,  Aug 25, 2014  12:00 AM ET

Rating:
Buy ITMN
up 66.80 %
Intermune, Inc. (ITMN) rated Buy with price target $52 by UBS
Thursday,  Jun 12, 2014  12:00 AM ET

Rating:
Buy ITMN
up 122.72 %

Rating:
Hold ITMN

Rating:
Hold ITMN
Intermune, Inc. (ITMN) rated Neutral by Credit Suisse
Friday,  Feb 28, 2014  8:25 AM ET

Rating:
Buy ITMN
up 119.28 %

Rating:
Hold ITMN
Intermune, Inc. (ITMN) rated Mkt Perform by Leerink Swann
Wednesday,  Feb 26, 2014  8:25 AM ET

Rating:
Buy ITMN
up 315.86 %

Rating:
Buy ITMN
up 611.94 %
Intermune, Inc. (ITMN) rated Buy with price target $19 by UBS
Friday,  Jan 10, 2014  11:25 AM ET

Rating:
Buy ITMN
up 307.43 %

Rating:
Buy ITMN
up 412.12 %

Rating:
Hold ITMN

Rating:
Buy ITMN
up 611.94 %
Intermune, Inc. (ITMN) upgraded to Buy by UBS
Wednesday,  Jan 16, 2013  8:25 AM ET

Rating:
Buy ITMN
up 96.49 %

Your Recent Stocks
SymbolLastChange
ITMN 73.89 down  -0.01 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy